Short-term effects of intravitreal bevacizumab (Avastin®) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration

Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab

(2010) K. Matsuyama et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin®) in neovascular age-related macular degeneration

(2009) Philippe Bonnin et al.   ACTA OPHTHALMOLOGICA

Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up

(2009) Rita Ehrlich et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion

(2009) Alexandra E. Hoeh et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Changes in choriocapillaris fenestration of rat eyes after intravitreal bevacizumab injection

(2009) Yukiko Shimomura et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Acute Vision Loss after Intravitreal Injection of Bevacizumab (Avastin) Associated with Ocular Ischemic Syndrome

(2009) Zei-Lun Huang et al.   OPHTHALMOLOGICA

Antiangiogenic Approaches to Age-Related Macular Degeneration Today

(2009) Neil M. Bressler   OPHTHALMOLOGY

Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans

(2008) Tim U. Krohne et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema

(2007) Wael Soliman et al.   ACTA OPHTHALMOLOGICA